Spectranetics Announces FDA Approval of Stellarex Drug-Coated Balloon
Technology | Drug-Eluting Balloons | July 26, 2017

July 26, 2017 — The Spectranetics Corp. announced receipt of U.S. Food and Drug Administration (FDA) pre-market...

First European Patient Enrolled in Intact Vascular's TOBA II BTK Trial
News | Stents Peripheral | July 26, 2017

July 26, 2017 — Intact Vascular Inc. recently announced that its Tack Optimized Balloon Angioplasty II Below the...

Videos | Peripheral Arterial Disease (PAD) | July 25, 2017

This video case study, provided by Gore Medical, is titled "Tackling Complex Cases in Dialysis Access," by John Ross...

First Patient Treated in U.S. Feasibility Study of LimFlow Critical Limb Ischemia Device
News | Peripheral Arterial Disease (PAD) | July 17, 2017

July 17, 2017 — LimFlow SA announced enrollment of the first patient in the U.S....

FDA Approves Six-Month Primary Endpoint for Tack Endovascular System in Below the Knee Disease
News | Stents Peripheral | July 14, 2017

July 14, 2017 — Intact Vascular Inc. announced the U.S. Food and Drug Administration (FDA) approved an...

Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients
News | Hemodynamic Monitoring Systems | July 14, 2017

July 14, 2017 — A review appearing in the July 18 issue of the...

Edwards Sapien 3 TAVR valve will be implanted in asymptomatic aortic stenosis patients in the EARLY TAVR Trial
Feature | Heart Valve Technology | July 14, 2017

July 14, 2017 — Morristown Medical Center, part of Atlantic Health System, has randomized the first patient in the...

long-duration dual anti-platelet therapy (L-DAPT) compared to short-duration dual antiplatelet (S-DAPT) after DES stent implantation
News | Antiplatelet and Anticoagulation Therapies | July 12, 2017

June 12, 2017 — Researchers have evaluated the long-term efficacy and safety of long-duration dual anti-platelet...

FFR-CT, heartflow

An example of an FFR-CT image, showing the FFR values for all coronary vessel segments and the reduction in hemodynamic flow after specific lesions.

News | CT Angiography (CTA) | July 12, 2017

July 12, 2017 — The American Medical Association (AMA) has granted a Category III Tracking Code for estimated...

Medtronic's CoreValve Evolut R gained FDA approval for intermediate risk patients

An illustration of the self-expanding CoreValve Evolut R TAVR valve half deployed in the aortic root.

Feature | Heart Valve Technology | July 10, 2017

July 10, 2017 — The U.S. Food and Drug Administration (FDA) has cleared an additional indication to expand the use...

Patient Race, Gender Both Important in Predicting Heart Attack Symptoms in the ER
News | Cath Lab | July 07, 2017

July 7, 2017 — Researchers at the George Washington University (GW) found that certain symptoms are more and less...

ACCESS PTS Study Demonstrates Efficacy of EKOS Therapy for Post-Thrombotic Syndrome
News | Deep Vein Thrombosis | July 07, 2017

July 7, 2017 — BTG plc recently highlighted the results of the ACCESS PTS trial, presented at the Society for...

Heartflow FFR-CT can noninvasively assess the hemodynamic impact of coronary lesions to avoid the need for an invasive angiogram.

HeartFlow FFR-CT can noninvasively assess the hemodynamic impact of coronary lesions to avoid the need for an invasive angiogram.

Technology | CT Angiography (CTA) | July 06, 2017

July 6, 2017 — GE Healthcare and HeartFlow Inc. announced at the annual scientific meeting of the Society of...

Siemens Healthineers Announces First U.S. Install of Artis Pheno Angiography System
News | Angiography | July 05, 2017

July 5, 2017 — Michigan Medicine recently became the first healthcare institution in the United States to install...

Pre-PCI Impella 2.5 Insertion Improves Survival in Left Main Coronary Artery Heart Attacks
News | Ventricular Assist Devices (VAD) | June 30, 2017

June 30, 2017 — Abiomed Inc. announced the recent publication of a peer-reviewed retrospective study on...

Overlay Init